Metastatic Malignant Female Reproductive System Neoplasm: Clinical Trials

6 trials for Metastatic Malignant Female Reproductive System Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 2 recruiting, 1 completed. 2 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Active not recruiting 2
Not applicable1Active not recruiting 1

Follow Metastatic Malignant Female Reproductive System Neoplasm: new trials by email Literature Review of Metastatic Malignant Female Reproductive System Neoplasm trials Research Report on Metastatic Malignant Female Reproductive System Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers
Malignant Female Reproductive System Neoplasm, Metastatic Malignant Female Reproductive System Neoplasm
RecruitingFred Hutchinson Cancer Center302026-11-012026-10-20
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel - Advanced Breast Carcinoma, Advanced Endometrial Carcinoma
Phase 1RecruitingM.D. Anderson Cancer Center432022-04-292026-07-16
A Nurse-Led Intervention for Fear of Progression in Advanced Cancer
Educational Intervention - Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Neoplasm
Not applicableActive not recruitingCity of Hope Medical Center422021-03-082026-08-19
Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers
3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, Quality-of-Life Assessment - Metastatic Malignant Female Reproductive System Neoplasm
Phase 2Active not recruitingM.D. Anderson Cancer Center282021-01-112026-09-18
Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
Durvalumab, Internal Radiation Therapy, Tremelimumab - Metastatic Malignant Female Reproductive System Neoplasm, Platinum-Resistant Malignant Female Reproductive System Neoplasm
Phase 2Active not recruitingJonsson Comprehensive Cancer Center92020-08-072026-07-17
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Malignant Peritoneal Neoplasm, Malignant Retroperitoneal Neoplasm
Phase 1CompletedM.D. Anderson Cancer Center262018-09-212025-05-22

Narrower conditions

Endometrial Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Lung Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Adnexal Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Ovarian Diseases (2)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Brachytherapy (1)  ·  CTLA-4 Antigen (1)  ·  Disulfides (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)  ·  Immunoglobulin G (1)  ·  Ipilimumab (1)  ·  Methods (1)  ·  Nivolumab (1)  ·  Pharmacogenomic Variants (1)  ·  Radiotherapy, Conformal (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Taxes (1)

Sponsors

M.D. Anderson Cancer Center (3)  ·  City of Hope Medical Center (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Jonsson Comprehensive Cancer Center (1)

Countries

United States (6)

Top investigators

Albert J Chang (1)  ·  Amir A Jazaeri (1)  ·  Anne Reb (1)  ·  Apostolia M Tsimberidou (1)  ·  Kalyan Banda, MD (1)  ·  Lauren Colbert (1)

Results publications

PMID 38471508

NIH funding

P30CA033572 (1)